Performance – After beginning the year in the ascendancy, helped by easing tensions between the US and Iran, the outbreak of coronavirus in China pulled the breaks on risk assets, particularly hitting Asian and resource funds. Significant selling has taken place in early February (not included in this roundup), following the end of the Chinese new year celebration. Out of the bottom 10 performers by NAV, seven were either Asian or resource-focused. Amongst the outperformers, New life-sciences fund, RTW Venture had the third best NAV return behind Manchester & London and Oakley Capital. Manchester & London’s NAV return owed to good months for tech-based holdings, including Amazon and Alphabet;
Discounts/premiums – Before January, Standard Life Private Equity’s discount had widened to a point where a lot of investors began to see value. Elsewhere, Baillie GiffordEuropean Growth’s share price has been increasing since Baillie Gifford took over the management contract from Edinburgh Partners. Several renewables funds came under attack (see the news section) from brokers, pulling down Bluefield Solar‘s premium;
Money in and out – It was a quiet month of fundraising with no major placings;
Major news stories – Renewable energy funds came under attack from brokers and SQN Asset Finance discussed the problems it was having with anaerobic digestion plants.
Edward Marten is MD of investor research company QuotedData. They provide free information for investors who find it hard to access high-quality, reliable, equity research on UK and European-listed companies. This is a QuotedData release.
